Literature DB >> 22409319

Distribution of the vanG-like gene cluster in Clostridium difficile clinical isolates.

Fariza Ammam1, Jean-Christophe Marvaud, Thierry Lambert.   

Abstract

Treatment of Clostridium difficile infections generally requires cessation of their causative antibiotic and subsequent administration of metronidazole or vancomycin. Intriguingly, the genome of C. difficile 630 contains a cryptic gene cluster homologous to the vanG-type operon of Enterococcus faecalis BM4518. We detected this cluster by PCR in 35 out of 41 clinical isolates, confirming its large prevalence in this species. The cluster was found to be located in a unique locus. Comparison of this locus with that of strains devoid of the vanG-like cluster indicated that acquisition of the gene cluster occurred in a perfect 19-bp inverted repeat, in the absence of a detectable mobile structure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22409319     DOI: 10.1139/w2012-002

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  14 in total

1.  Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates.

Authors:  Wan-Jou Shen; Aditi Deshpande; Kirk E Hevener; Bradley T Endres; Kevin W Garey; Kelli L Palmer; Julian G Hurdle
Journal:  J Antimicrob Chemother       Date:  2020-04-01       Impact factor: 5.790

2.  Examination of the Clostridioides (Clostridium) difficile VanZ ortholog, CD1240.

Authors:  Emily C Woods; Daniela Wetzel; Monjori Mukerjee; Shonna M McBride
Journal:  Anaerobe       Date:  2018-06-22       Impact factor: 3.331

3.  A Clostridium difficile Lineage Endemic to Costa Rican Hospitals Is Multidrug Resistant by Acquisition of Chromosomal Mutations and Novel Mobile Genetic Elements.

Authors:  Gabriel Ramírez-Vargas; Carlos Quesada-Gómez; Luis Acuña-Amador; Diana López-Ureña; Tatiana Murillo; María Del Mar Gamboa-Coronado; Esteban Chaves-Olarte; Nicholas Thomson; Evelyn Rodríguez-Cavallini; César Rodríguez
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 4.  Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection.

Authors:  Patrizia Spigaglia
Journal:  Ther Adv Infect Dis       Date:  2016-02

Review 5.  Antimicrobial resistance in Clostridioides difficile.

Authors:  Keeley O'Grady; Daniel R Knight; Thomas V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-08-24       Impact factor: 3.267

6.  A Phenotypically Silent vanB2 Operon Carried on a Tn1549-Like Element in Clostridium difficile.

Authors:  Daniel R Knight; Grace O Androga; Susan A Ballard; Benjamin P Howden; Thomas V Riley
Journal:  mSphere       Date:  2016-08-10       Impact factor: 4.389

Review 7.  Clostridioides difficile as a Dynamic Vehicle for the Dissemination of Antimicrobial-Resistance Determinants: Review and In Silico Analysis.

Authors:  Philip Kartalidis; Anargyros Skoulakis; Katerina Tsilipounidaki; Zoi Florou; Efthymia Petinaki; George C Fthenakis
Journal:  Microorganisms       Date:  2021-06-25

Review 8.  Mechanisms of antibiotic resistance of Clostridioides difficile.

Authors:  Ishani Wickramage; Patrizia Spigaglia; Xingmin Sun
Journal:  J Antimicrob Chemother       Date:  2021-11-12       Impact factor: 5.758

9.  vanG element insertions within a conserved chromosomal site conferring vancomycin resistance to Streptococcus agalactiae and Streptococcus anginosus.

Authors:  Velusamy Srinivasan; Benjamin J Metcalf; Kristen M Knipe; Mahamoudou Ouattara; Lesley McGee; Patricia L Shewmaker; Anita Glennen; Megin Nichols; Carol Harris; Mary Brimmage; Belinda Ostrowsky; Connie J Park; Stephanie J Schrag; Michael A Frace; Scott A Sammons; Bernard Beall
Journal:  MBio       Date:  2014-07-22       Impact factor: 7.867

Review 10.  Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection.

Authors:  Simon D Baines; Mark H Wilcox
Journal:  Antibiotics (Basel)       Date:  2015-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.